Interleukin-8 gene polymorphism and susceptibility to gastric cancer in a brazilian population

Biological Research

Volumn 45, Issue 4, 2012, Pages 369-374

  Felipe, Aledson V ^a   Silva, Tiago D ^a   Pimenta, Célia A ^a   Kassab, Paulo ^b   Forones, Nora M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Santa Casa de Misericórdia de São Paulo   (Brazil)

Author keywords

Gastric cancer; IL 8; Polymorphism

Indexed keywords

INTERLEUKIN 8;

BRAZIL; CASE CONTROL STUDY; COMPLICATION; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; KAPLAN MEIER METHOD; MALE; MICROBIOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STOMACH TUMOR; ARTICLE;

BRAZIL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84875287690     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602012000400007     Document Type: Article

References (40)

1. BACON K, BAGGIOLINI M, BROXMEYER H, HORUK R, LINDLEY I, MANTOVANI A, MAYSUSHIMA K, MURPHY P, NOMIYAMA H, OPPENHEIM J, ROT A, SCHALL T, TSANG M, THORPE R, VAN DAMME J, WADHWA M, YOSHIE O, ZLOTNIK A, ZOON K (2002) Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 10:1067-1068.
2. BRASIL (2010) Ministério da Saúde. Instituto Nacional do Câncer (INCA): Data base: http://www1.inca.gov.br/estimativa/2010/Accessed: July, 2010.
3. BUCKLAND G, BACH A, SERRA-MAJEM L (2010) Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr 91:381-390.
4. CLORE GM, APPELLA E, YAMADA M, MA/TSUSHIMA K, GRONENBORN AM, (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry. 29:1689-96.
5. CORREA P (1988) A human model of gastric carcinogenesis. Cancer Res 48:3554-3560.
6. CRABTREE JE, XIANG Z, LINDLEY IJ, TOMPKINS DS, RAPPUOLI R, COVACCI A (1995) Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 48:967-969.
7. CREW KD, NEUGUT AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354-362.
8. DANESH J (1999) Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 13:851--856.
9. ESLICK GD, LIM LL, BYLES JE, XIA HH, TALLEY NJ (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94:2373-2379.
10. FERLAY J,AUTIER P, BONIOL M, HEANUE M, COLOMBET M, BOYLE P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592.
11. FUKASE K, KA/TO M, KIKUCHI S, INOUE K, UEMURA N, OKAMOTO S, TERAO S, AMAGAI K, HAYASHI S, ASAKA M (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet. 372:392-397.
12. GARZA-GONZÁLEZ E, BOSQUES-PADILLA FJ, MENDOZA-IBARRA SI, FLORES-GUTIÉRREZ JP, MALDONADO-GARZA HJ, PÉREZ-PÉREZ GI (2007) Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 26:70.
13. HAMAJIMA N, NAITO M, KONDO T, GOTO Y (2006) Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci 97:1129-1138.
14. JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, MURRAY T, THUN MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
15. JOOSSENS JV, HILL MJ, ELLIOTT P, STAMLER R, LESAFFRE E, DYER A, NICHOLS R, KESTELOOT H. (1996) Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 25:494-504.
16. KAMANGAR F, ABNET CC, HUTCHINSON AA, NEWSCHAFFER CJ, HELZLSOUER K, SHUGART YY, PIETINEN P, DAWSEY SM, ALBANES D, VIRTAMO J, TAYLOR PR (2006) Polymorphisms in inflammationrelated genes and risk of gastric cancer (Finland). Cancer Causes Control. 17:117-125.
17. KARASHIMA T, SWEENEY P, KAMAT A, HUANG S, KIM S J, BAR-ELI M, MCCONKEY D J, DINNEY C P N. (2003) Nuclear Factor-B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-8. Clinical Cancer Research. 9:2786-2797.
18. KONO S, HIROHA T (1996) Nutrition and stomach cancer. Cancer causes control 7:41-55.
19. LADEIRAS-LOPES R, PEREIRA AK, NOGUEIRA A, PINHEIRO-TORRES T, PINTO I, SANTOS-PEREIRA R, LUNET N (2008) Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 19:689-701.
20. TORRE MD (1997) Stomach cancer mortality in Brazil: from 1977 to 1989. Cad Saude Publica. 13:67-78.
21. LEE W P, TAI D I, LAN K H, LI A F Y, HSU H C, LIN E J, LIN Y P, SHEU M L, LI C P, CHANG F Y, CHAO Y, YEN S H, LEE S D (2005) The -251T allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population. Clin Cancer Research 11:6431-6441.
22. LU W, PAN K, ZHANG L, LIN D, MIAO X, YOU W (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor a and risk of gastric cancer in a Chinese population. Carcinogenesis 26:631-636.
23. LURJE G, HUSAIN H, POWER DG, YANG D, GROSHEN S, POHL A, ZHANG W, NING Y, MANEGOLD PC, EL-KHOUEIRY A, IQBAL S, TANG LH, SHAH MA, LENZ HJ (2010) Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol 21:78-86.
24. MATYSIAK-BUDNIKA T, ME ́GRAUDB F (2006) H. pylori infection and gastric cancer. European Journal of Cancer 42:708-716.
25. OHYAUCHI M, IMA/TANI A, YONECHI M, ASANO N, MIURA A, IIJIMA K, KOIKE T, SEKINE H, OHARA S, SHIMOSEGAWA T (2005) The polymorphism interleukin 8 -251 A/T influences the susceptibility of H. pylori related gastric diseases in the Japanese population. GUT 5:330-335.
26. PERSSON C, CANEDO P, MACHADO JC, EL-OMAR EM, FORMAN D (2011) Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and metaanalyses. Am J Epidemiol 173:259-270.
27. SALVO VL, GIMENO SG (2002) Reproducibility and validity of a food frequency questionnaire. Rev Saude Publica 36:505-512.
28. SARVESTANI E K, BAZARGANI A, MASOUDIAN M, LANKARANI K, TAGHAVI AR, SABERIFIROOZI M (2006) Association of H pylori cagA and vacA genotypes and IL-8 (rs4073) gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 12:5205-5210.
29. SAVAGE SA, HOU L, LISSOWSKA J, CHOW WH, ZA/TONSKI W, CHANOCK SJ, YEAGER M (2006) Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population. Cancer Epidemiol Biomarkers Prev 15: 589-591.
30. SHARMA SA, TUMMURU MK, BLASER MJ, KERR LD (1998) Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160:2401-2407.
31. SHIRAI K, OHMIYA N, TAGUCHI A, MABUCHI N, YA/TSUYA H, ITOH A, HIROOKA Y, NIWA Y, MORI N, GOTO H (2006) Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. Journal of Gastroenterology and Hepatology 21:1129-1135.
32. SONG BO, ZHANG DIANLIANG, ZHENG HONGME, WANG XINXIANG, ZHOU YANBING, LIU XIAOBO (2010) Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. J Interferon Cytokine Res 30:9-14.
33. TAGUCHI A, OHMIYA N, SHIRAI K, MABUCHI N, ITOH A, HIROOKA Y, NIWA Y, GOTO H (2005) Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan. Cancer Epidemiol Biomarkers Prev 14:2478-2493.
34. TEIXEIRA JBA, NOGUEIRA MS. (2003) Gastric cancer: risk factors in patients treated in tertiary care services of a municipality in the interior of the state of Sao Paulo. Rev Latino-am Enfermagem 11:43-48.
35. TOROK AM, BOUTON AH, GOLDBERG JB (2005) H. pylori Induces Interleukin-8 Secretion by Toll-Like Receptor 2 and Toll-Like Receptor 5-Dependent and - Independent Pathways. Infection and Immunity 73:1523-1531.
36. UEMURA N, OKAMOTO S, YAMAMOTO S, MATSUMURA N, YAMAGUCHI S, YAMAKIDO M, TANIYAMA K, SASAKI N, SCHLEMPER RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789.
37. WEN S, MOSS SF (2009) H. pylori virulence factors in gastric carcinogenesis. Cancer Lett 282:1-8.
38. WOLFF B, BURNS AR, MIDDLETON J, ROT A (1998) Endothelial Cell "Memory" of Inflammatory Stimulation: Human Venular Endothelial Cells Store Interleukin 8 in Weibel-Palade Bodies. J. Exp. Med 188:1757--1762.
39. WONG BC, LAM SK, WONG WM, CHEN JS, ZHENG TT, FENG RE, LAI KC, HU WH, YUEN ST, LEUNG SY, FONG DY, HO J, CHING CK, CHEN JS (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291:187-194.
40. YAMAOKA Y, KWON DH, GRAHAM DY (2000) A M(r) 34, 000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 97:7533-7538.